Publications 2025

Sort by: Date | Author | Title

Laursen, T., Jørgensen, J. O. L. & Christiansen, J. S. (2008). The management of adult growth hormone deficiency syndrome. Expert Opinion on Pharmacotherapy, 9(14), 2435-50. https://doi.org/10.1517/14656566.9.14.2435

Jessen, N. (2007). Aspects of Insulin Signaling in Skeletal Muscle. Dansk Medical Bulletin.

Marier, J.-F., Lor, M., Morin, J., Roux, L., Di Marco, M., Morelli, G. & Saedder, E. A. (2007). Comparative bioequivalence study between a novel matrix transdermal delivery system of fentanyl and a commercially available reservoir formulation. British Journal of Clinical Pharmacology. Supplement, 63(1), 121-4. https://doi.org/10.1111/j.1365-2125.2006.02758.x

Parkner, T., Laursen, T., Lauritzen, T., Smedegaard, J. S. & Christiansen, J. S. (2007). Constant Subcutaneous Insulin Infusion versusLong-acting Insulin Injection as supplement to Oral Anti-diabetic Drugs inType 2 Diabetic Patients. In Diabetes (Vol. 56 (Suppl. 1), pp. A551). American Diabetes Association.

Gormsen, L. C., Jessen, N., Gjedsted, J., Gjedde, S., Nørrelund, H., Lund, S., Christiansen, J. S., Nielsen, S., Schmitz, O. & Møller, N. (2007). Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans. Journal of Clinical Endocrinology and Metabolism, 92(5), 1834-42.

Gormsen, L. C., Nielsen, C., Jessen, N., Vestergaard, E. T., Christiansen, J. S., Jørgensen, J. O. L. & Møller, N. (2007). Effects of physiological bell-shaped elevations of free fatty acids on glucose metabolism and insulin sensitivity in humans. In Endocrine Abstracts (Vol. 14, pp. P210)

Vestergaard, E. T., Jessen, N., Gormsen, L. C., Lund, S., Møller, N. & Jørgensen, J. O. L. (2007). Ghrelin-induced GH release translates into GH signaling in skeletal muscle - in vivo studies in human subjects. In ENDO 07 - Meeting Follow-up Endocrine Society.

Jørgensen, J. O. L., Larsen, RL., Møller, L., Krag, M. B., Jessen, N., Nørrelund, H., Christiansen, J. S. & Møller, N. (2007). Growth hormone and insulin resistance. Hormone Research, Suppl. 1, 33-36.

Husted, S. & Ziegler, B. K. (2007). Guidelines and recommandations. In E. Falk, S. PK & P. J. de Feyter (Eds.), Ischemic Heart Disease (pp. 266-268). Manson Publishing Ltd..

Jessen, N., Østergård, T., Lihn, A. M., Pedersen, S. B., Lund, S. & Schmitz, O. (2007). Long Term Exercise in First Degree Relatives Improves Insulin Signaling in Adipose Tissue. In Diabetes (Vol. Suppl.1, pp. A364). American Diabetes Association.

Laursen, T. & Kristensen, L. Ø. (2007). Midler ved sygdomme i hypothalamus og hyposyse - Binyrebarksteroider og androgener. In J. P. Kampmann, K. Brøsen & U. Simonsen (Eds.), Basal og klinisk farmakologi (3., 1. oplag ed., pp. 383-397). FADL's Forlag.

Krag, K. S., Gravholt, C. H., Laursen, T., Laurberg, P., Andersen, M., Østergaard Kristensen, L., Feldt-Rasmussen, U., Christiansen, J. S., Frydenberg, M. & Greeen, A. (2007). Mortality and GH deficiency: a nationwide study. European Journal of Endocrinology, 157(1), 9-18.

Stochholm, K., Christiansen, J., Laursen, T. & Gravholt, C. H. (2007). Mortality and reduced growth hormone secretion. Hormone Research, 68 Suppl 5(5), 173-6. https://doi.org/10.1159/000110618

Parkner, T., Laursen, T., Chen, J.-W., Møller, M. K., Thomsen, H. F., Jørgensen, C., Smedegaard, J. S., Lauritzen, T. & Christiansen, J. S. (2007). Overnight versus 24 hours of continuous subcutaneous insulin infusion as supplement to oral antidiabetic drugs in type 2 diabetes. Journal of Diabetes Science and Technology, 1(5), 704-10. https://doi.org/10.1177/193229680700100514

Jørgensen, J. O. L., Vestergaard, E. T., Krag, M. B., Nielsen, C., Møller, L. & Jessen, N. (2007). Skeletal muscle as a metabolic target for growth hormone. Hormone Research, 66(Suppl. 1), 22-25.

Laursen, T., Mindeholm, L., Haemmerle, S., Ferreira, A., Jørgensen, J. O. L., Azria, M. & Christiansen, J. S. (2007). A novel oral preparation of human growth hormone (hGH) is absorbed and increases serum IGF-I levels after 7 days administration to GH-deficient adults. In Clinical - Physiology & Pharmacology of the Growth Hormone Axis: New Treatment Modalities & Indications US Endocrine Society.

Petersen, A. H., Kohler, G., Korsatko, S., Wutte, A., Wonisch, M., Jeppesen, OK., Sparre, T., Clauson, P., Laursen, T., Wollmer, P. & Pieber, T. R. (2007). The effect of exercise on the absorption of inhaled human insulin via the AERx(R) iDMS in people with type 1 diabetes. Diabetes Care, 30(10), 2571-2576.

Østergård, T., Jessen, N., Schmitz, O. & Mandarino, L. J. (2007). The effect of exercise, training, and inactivity on insulin sensitivity in diabetics and their relatives: what is new? Appl. Physiol. Nutri. Metab., 32, 541-8.

Petersen, A. H., Laursen, T., Ahrén, B., Pieber, T., Clauson, P. & Wollmer, P. (2007). The impact of large tidal volume ventilation on the absorption of inhaled insulin in rabbits. Eur J Pharm Sci, 30(3-4), 351-357.

Kjølby, M. F., Müller, K. & Schumacher, M. (2006). Cerebellopontine angle primary diffuse large B cell (non-Hodgkins) lymphoma mimicking an acoustic schwannoma. European Journal of Radiology Extra, 60(3), 93-96.

Kramer, H. F., Witczak, C. A., Fujii, N., Jessen, N., Taylor, E. B., Arnolds, D. E., Sakamoto, K., Hirshman, M. F. & Goodyear, L. J. (2006). Distinct Signals Regulate AS160 Phosphorylation in Response to Insulin, AICAR, and Contraction in Mouse Skeletal Muscle. Diabetes, 55(7), 2067-2076.

Jørgensen, J. O. L., Jessen, N., Pedersen, S. B., Vestergaard, E. T., Gormsen, L. C., Lund, S. & Billestrup, N. (2006). GH receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus. Am. J. Physiol. Endocrinol. Metab., 291(5), E899-905.

Jessen, N., Buhl, E. S., Schmitz, O. & Lund, S. (2006). Impaired insulin action despite upregulation of proximal insulin signaling: Novel insights into skeletal muscle insulin resistance in liver cirrhosis. J. Hepatol., 45((6)), 797-804.

Jessen, N., Buhl, E. S., Schmitz, O. & Lund, S. (2006). Impaired Insulin Action Despite Upregulation of Proximal Insulin Signaling: Novel Insights into SkeletalMuscle Insulin Resistance in Liver Cirrhosis. Abstract from Impaired Insulin Action Despite Upregulation of Proximal Insulin Signaling: Novel Insights into SkeletalMuscle Insulin Resistance in Liver Cirrhosis, 42nd EASD Annual Meeting, Denmark.

Stochholm, K., Gravholt, C. H., Laursen, T., Jørgensen, J. O. L., Laurberg, P., Andersen, M., Kristensen, L. Ø., Feldt-Rasmussen, U., Christiansen, J. S., Frydenberg, M. & Green, A. (2006). Incidence of GH deficiency: a nationwide study. European Journal of Endocrinology, 155(1), 61-71.

Witczak, C. A., Hirshman, M. F., Jessen, N., Fujii, N., Seifert, M. M., Brandauer, J., Hotamisligil, G. S. & Goodyear, L. J. (2006). JNK1 deficiency does not enhance muscle glucose metabolism in lean mice. Biochem. Biophys. Res. Commun., 350(4), 1063-1068.

Husted, S., Ziegler, B. K. & Kher, A. (2006). Long-term anticoagulant therapy in patients with coronary artery disease. European Heart Journal, 27, 913-19.

T., L., Hansen, B. & Fisker, S. (2006). Pain perception after subcutaneous injections of media containing different buffers. Basic Clin. Pharmacol. Toxicol., 98(2), 218-221.

Marier, J.-F., Lor, M., Potvin, D., Dimarco, M., Morelli, G. & Saedder, E. A. (2006). Pharmacokinetics, tolerability, and performance of a novel matrix transdermal delivery system of fentanyl relative to the commercially available reservoir formulation in healthy subjects. The Journal of Clinical Pharmacology, 46(6), 642-53. https://doi.org/10.1177/0091270006286901

Kramer, H. F., Witczak, C. A., Hirshmann, M. F., Fujii, N., Jessen, N., Ho, R., Sakamoto, K., Lienhard, G. E. & Goodyear, L. J. (2006). Rab-GAP AS160 is differentially regulated by multiple effectors of glucose transport in mouse skeletal muscle. In Ikke angivet (pp. A1280-A1280). FASEB JOURNAL.

Koh, H.-J., Arnolds, D. E., Fujii, N., Tran, T. T., Rogers, M. J., Jessen, N., Li, Y., Liew, C. W., Ho, R. C., Hirshman, M. F., Kulkarni, R. N., Kahn, C. R. & Goodyear, L. J. (2006). Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Molecular and Cellular Biology, 26(22), 8217-27. https://doi.org/10.1128/MCB.00979-06

Fujii, N., Jessen, N. & Goodyear, L. J. (2006). The Role of AMPK in Glucose Uptake. Am. J. Physiol. Endocrinol. Metab., 291(5), E867-877.

Kramer, H. F., Fujii, N., Ho, R. C., Witczak, C. A., Jessen, N., Hirshman, M. F., Lienhard, G. E. & Goodyear, L. J. (2005). AS160 regulates contraction-stimulated glucose transport in mouse skeletal muscle. Abstract from American Heart Association's Scientific Sessions 2005, Dallas, TX, USA , United States.

Jessen, N. & Goodyear, L. J. (2005). Contraction signaling to glucose transport in skeletal muscle. J. Appl. Physiol., 99, 330-337.

Kjølby, M. F., Kompanowska-Jezierska, E., Wamberg, S. & Bie, P. (2005). Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs. Acta Physiologica (Print), 184(3), 225-234.

Jessen, N., Djurhuus, C. B., Jorgensen, J. O., Jensen, L. S., Møller, N., Lund, S. & Schmitz, O. (2005). Evidence against a role for insulin-signaling proteins PI3-kinase and Akt in insulin resistance in human skeletal muscle induced by short term GH-infusion. Am. J. Physiol. Endocrinol. Metab., (288(1)), 194-199.

Witczak, C., Jessen, N., Hotamisligil, G. S., Hirshman, M. F. & Goodyear, L. J. (2005). JNK1 deficiency enhances whole body glucose metabolism, but not via alterations in skeletal muscle. Abstract from American Diabetes Association 65th Scientific Sessions, San Diego, CA, USA , United States.

Jessen, N., Koh, H. J., Arnolds, D. E., Mukai, N., Hirshman, M. F., Fujii, N. & Goodyear, L. J. (2005). LKB1 is-a critical regulator of AMPK in heart. Abstract from American Diabetes Association 65th Scientific Sessions, San Diego, CA, USA , United States.

Pold, R., Jensen, L. S., Jessen, N., Buhl, E. S., Schmitz, O., Flyvbjerg, A., Fujii, N., Goodyear, L. J., Gotfredsen, C. F., Brand, C. L. & Lund, S. (2005). Long-term AICAR administration and exercise prevents diabetes in ZDF rats. Diabetes, (54(4)), 928-934.

Jørgensen, J. O. L., Vestergaard, E. T., Gormsen, L. C., Jessen, N., Nørrelund, H., Christiansen, J. S. & Møller, N. (2005). Metabolic consequences of GH deficiency. J. Endocrinol. Invest., 28, 47-51.

Jensen, L. S., Nielsen, J. M., Loefgren, B., Kristiansen, S. B., Jessen, N., Nielsen, T. T., Bøtker, H. E., O., S. & Lund, S. (2005). Metformin activates AMP-activated protein kinase (AMPK) in the rat heart and reduces myocardial infarct size 24 hours later. Abstract from 41st EASD Meeting, Athens, Greece, Greece.

Buhl, C., Buhl, E. S., Petersen, C. N., Jessen, N., O., S. & Lund, S. (2005). No inhibitory effect of TNF alpha on insulin-stimulated glucose uptake in in situ skeletal muscle. Abstract from 41st EASD Meeting, Athens, Greece, Greece.

Koh, H. J., Hirshman, M. F., Fujii, N., Arnolds, D. E., Rogers, M. J., Mukai, N., Jessen, N., Ho, R. C. & Goodyear, L. J. (2005). Skeletal muscle-specific knockout of LKB1 causes AICAR resistance but improves glucose tolerance. Abstract from American Diabetes Association 65th Scientific Sessions, San Diego, CA, USA, United States.

Lihn, A. S., Jessen, N., Richelsen, B., Pedersen, S. B. & Lund, S. (2004). AICAR stimulates adiponectin and inhibits cytokines in adipose tissue. Biochen Biophys Res Commun, 316, 853-858.

Laursen, T. (2004). Clinical pharmacological aspects of growth hormone administration. Growth. Horm. IGF. Res., (14(1)), 16-44.

Laursen, T. (2004). Clinical pharmacological aspects of growth hormone administration.

Lindgren, A., Husted, S., Staaf, G. & Ziegler, B. (2004). Dipyridamole and headache - a pilot study of initial dose titration. J Neurol Sci, 223, 179-184.

Lindgren, A., Husted, S., Staaf, G. & Ziegler, B. K. (2004). Dipyridamole and headache - a pilot study of initial dose titration. J Neur Sci, 223, 179-184.

Husted, S. & Ziegler, B. K. (2004). Evidence for the benefits of the low-molecular-weight heparin dalteparin in “high-risk” patients with acute coronary syndromes. Cardiology, 4, 157-163.

Husted, S. & Ziegler, B. (2004). Evidence for the Benefits of the Low-Molecular-Weight Heparin Dalteparin in "High-Risk" Patients with Acute Coronary Syndromes. Cardiology, 4, 157-163.

Displaying results 651 to 700 out of 716

Revised 15.04.2025

Ellen Kristensen